Key Takeaways: China's two largest state capital operators poured more than 60 billion yuan into A-shares on July 19, the most aggressive government intervention since the 2024 market rescue campaign.
Back
China state funds inject 60 billion yuan to stabilize A-shares
China's top state capital operators injected more than 60 billion yuan ($8.3 billion) into A-shares on July 19, the most direct government intervention since the 2024 rescue campaign, as regulators moved to halt a deepening selloff that has wiped more than 4 trillion yuan from the STAR Market alone.
"The market adjustment has not changed the fundamentals, and joint forces to stabilize expectations are rapidly gathering," the Shanghai Securities News reported, citing the coordinated actions by China Reform Holdings and China Chengtong. The two state-owned capital operating companies simultaneously announced their A-share buyback and investment plans, with combined commitments exceeding 60 billion yuan, and explicitly stated their firm confidence in the development prospects of China's capital market. The purchases represent the first time both entities have acted in concert since the 2024 stabilization effort, when similar coordinated buying helped reverse a three-month decline.
The intervention comes as the STAR Market, home to many of China's leading chip stocks, has plunged roughly 25% from its July 1 peak, erasing over 4 trillion yuan ($590 billion) of market value, according to exchange data. The broader CSI 300 Index has fallen to near its 2026 lows, while the Shanghai Composite has shed more than 8% since the start of the second half. The selloff has dented demand even for high-profile listings — CXMT Corp's $8.6 billion Shanghai IPO, Asia's largest so far this year, was oversubscribed 570 times by institutional investors, a fraction of the 5,000-times oversubscription ratios seen in recent STAR Market debuts from companies such as Zhuhai Trinomab Pharmaceutical and Chongqing Genori Technology. The retail tranche was oversubscribed 244 times, also pointing to diminished investor fervor ahead of CXMT's expected debut on July 27.
The coordinated action signals the government's determination to defend market stability ahead of a busy IPO pipeline that includes several state-backed technology listings. The China Securities Regulatory Commission has scheduled a symposium on July 20 with listed companies, securities firms and fund institutions to solicit opinions on promoting stable capital market development. People close to the regulator indicated the symposium would cover market liquidity conditions, IPO pacing, and potential measures to encourage long-term capital inflows, according to the Shanghai Securities News. The CSRC's willingness to engage directly with market participants marks a shift from the more indirect communication style that characterized earlier interventions.
The last time Beijing deployed state capital operators at this scale was during the 2024 market rout, when the CSI 300 rebounded 18% over the following three months. That recovery was fueled by a combination of state fund buying, regulatory easing on margin trading, and a suspension of new IPO approvals — tools the CSRC may now consider reactivating. For global investors, the intervention provides a clear signal that Beijing views current valuations as unsupportable and is willing to deploy fiscal resources to defend them, even as the broader economy faces headwinds from the property sector slowdown and subdued consumer confidence.
With the CSRC symposium scheduled for July 20 and additional state fund purchases expected to continue, the coming week will test whether Beijing's latest rescue effort can break the cycle of declining confidence that has gripped Chinese equities since the STAR Market peak on July 1. The outcome will also determine the reception for CXMT's listing on July 27 and a pipeline of follow-on offerings that collectively represent the largest test of China's IPO market since the 2024 recovery.
This article is for informational purposes only and does not constitute investment advice.
